MASECO Private Wealth’s AbbVie ABBV Stock Holding History

MASECO Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.41M	Sell	5,400 -46	-0.8%	-$11.8K	0.04%	61
2026 Q2	$1.37M	Sell	5,446 -29	-0.5%	-$6.24K	0.04%	58
2026 Q1	$1.19M	Sell	5,475 -36	-0.7%	-$7.99K	0.04%	57
2025 Q4	$1.26M	Sell	5,511 -2,780	-34%	-$633K	0.05%	51
2025 Q3	$1.92M	Buy	8,291 +1,000	+14%	+$204K	0.09%	30
2025 Q2	$1.35M	Buy	+7,291	New	+$1.36M	0.05%	56

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

MASECO Private Wealth's ABBV Position: Q3 2026 in Review

MASECO Private Wealth reduced its AbbVie (ABBV) stake by 0.84% in Q3 2026, selling an estimated $11.8K and leaving 5,400 shares worth $1.41M. The position accounts for 0.04% of the portfolio, ranked #61.

MASECO Private Wealth first reported a position in ABBV in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.92M in Q3 2025. 1,620 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

MASECO Private Wealth held 5,400 shares of AbbVie worth $1.41M as of Q3 2026.
MASECO Private Wealth sold 46 AbbVie shares in Q3 2026, an estimated $11.8K.
AbbVie made up 0.04% of MASECO Private Wealth's portfolio in Q3 2026, its #61 holding.
MASECO Private Wealth first reported a position in AbbVie in Q2 2025 and has held it in 6 quarters since.
MASECO Private Wealth's AbbVie position peaked at $1.92M in Q3 2025.
1,620 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on MASECO Private Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.